The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies.

ABSTRACT:

Background

Relapsed refractory multiple myeloma (RRMM) is a disease that is nonresponsive or progressive on therapy, and although patients can achieve remission, relapse is common. As more treatment options become available for multiple myeloma (MM), it is important to understand patients' experiences of current and emerging therapies.

Aims

This study aimed to better understand patient experiences with treatment and therapies for MM using qualitative interviews and patient-reported information (PRI) shared on social media.

Methods

Semistructured qualitative interviews were conducted with adults with RRMM who resided in the United States. In addition to the interviews, PRI was collected from YouTube and a patient advocacy website. Key themes from the interviews and PRI

SUBMITTER: Crawford R 

PROVIDER: S-EPMC9675381 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature